

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | maturation of SSU-rRNA (GO:0030490) | 9.30497978 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 8.86104618 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.35125385 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.09696900 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.09696900 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 6.71086598 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.71086598 |
| 8 | hemidesmosome assembly (GO:0031581) | 6.09860348 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 5.63237739 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.60975640 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.35069304 |
| 12 | axon ensheathment in central nervous system (GO:0032291) | 5.10802792 |
| 13 | central nervous system myelination (GO:0022010) | 5.10802792 |
| 14 | serine family amino acid biosynthetic process (GO:0009070) | 5.07712874 |
| 15 | cysteine metabolic process (GO:0006534) | 5.06717713 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.02701675 |
| 17 | fatty acid elongation (GO:0030497) | 4.99854551 |
| 18 | L-serine metabolic process (GO:0006563) | 4.95551103 |
| 19 | heme transport (GO:0015886) | 4.92748012 |
| 20 | bile acid biosynthetic process (GO:0006699) | 4.83394292 |
| 21 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.60218362 |
| 22 | very long-chain fatty acid metabolic process (GO:0000038) | 4.45413614 |
| 23 | tyrosine metabolic process (GO:0006570) | 4.40498712 |
| 24 | homocysteine metabolic process (GO:0050667) | 4.40441626 |
| 25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.37746714 |
| 26 | diol metabolic process (GO:0034311) | 4.35737531 |
| 27 | serine family amino acid metabolic process (GO:0009069) | 4.35430776 |
| 28 | tryptophan catabolic process (GO:0006569) | 4.31931981 |
| 29 | indole-containing compound catabolic process (GO:0042436) | 4.31931981 |
| 30 | indolalkylamine catabolic process (GO:0046218) | 4.31931981 |
| 31 | lysine metabolic process (GO:0006553) | 4.24440115 |
| 32 | lysine catabolic process (GO:0006554) | 4.24440115 |
| 33 | kynurenine metabolic process (GO:0070189) | 4.24019730 |
| 34 | DNA unwinding involved in DNA replication (GO:0006268) | 4.19495497 |
| 35 | tryptophan metabolic process (GO:0006568) | 4.18560092 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.18141485 |
| 37 | protein carboxylation (GO:0018214) | 4.17448402 |
| 38 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.17448402 |
| 39 | glycine metabolic process (GO:0006544) | 4.13474949 |
| 40 | bile acid metabolic process (GO:0008206) | 4.07878892 |
| 41 | regulation of protein activation cascade (GO:2000257) | 4.05336728 |
| 42 | ethanol oxidation (GO:0006069) | 4.02936135 |
| 43 | sphingoid metabolic process (GO:0046519) | 4.02259240 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.01813321 |
| 45 | branched-chain amino acid catabolic process (GO:0009083) | 3.99760558 |
| 46 | high-density lipoprotein particle remodeling (GO:0034375) | 3.96693575 |
| 47 | dopamine transport (GO:0015872) | 3.94752727 |
| 48 | mRNA splice site selection (GO:0006376) | 3.94380258 |
| 49 | serine family amino acid catabolic process (GO:0009071) | 3.93244303 |
| 50 | aspartate family amino acid catabolic process (GO:0009068) | 3.91568513 |
| 51 | short-chain fatty acid metabolic process (GO:0046459) | 3.89445012 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 3.88443743 |
| 53 | complement activation, alternative pathway (GO:0006957) | 3.85952565 |
| 54 | regulation of complement activation (GO:0030449) | 3.85845984 |
| 55 | cholesterol biosynthetic process (GO:0006695) | 3.83061749 |
| 56 | negative regulation of fibrinolysis (GO:0051918) | 3.80039257 |
| 57 | imidazole-containing compound metabolic process (GO:0052803) | 3.76402713 |
| 58 | drug transmembrane transport (GO:0006855) | 3.75746297 |
| 59 | acetyl-CoA metabolic process (GO:0006084) | 3.75541144 |
| 60 | amino-acid betaine metabolic process (GO:0006577) | 3.75523940 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 3.75463514 |
| 62 | cellular modified amino acid catabolic process (GO:0042219) | 3.74528772 |
| 63 | coenzyme catabolic process (GO:0009109) | 3.74487012 |
| 64 | response to methylmercury (GO:0051597) | 3.72444053 |
| 65 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.70163116 |
| 66 | regulation of fibrinolysis (GO:0051917) | 3.67228643 |
| 67 | urea metabolic process (GO:0019627) | 3.62669185 |
| 68 | urea cycle (GO:0000050) | 3.62669185 |
| 69 | glutamate metabolic process (GO:0006536) | 3.61980306 |
| 70 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.61644336 |
| 71 | iron coordination entity transport (GO:1901678) | 3.57374361 |
| 72 | trophectodermal cell differentiation (GO:0001829) | 3.56484542 |
| 73 | cellular ketone body metabolic process (GO:0046950) | 3.55592027 |
| 74 | iron ion import (GO:0097286) | 3.53823757 |
| 75 | polyketide metabolic process (GO:0030638) | 3.52177777 |
| 76 | doxorubicin metabolic process (GO:0044598) | 3.52177777 |
| 77 | daunorubicin metabolic process (GO:0044597) | 3.52177777 |
| 78 | branched-chain amino acid metabolic process (GO:0009081) | 3.52175865 |
| 79 | protein-lipid complex remodeling (GO:0034368) | 3.52040343 |
| 80 | macromolecular complex remodeling (GO:0034367) | 3.52040343 |
| 81 | plasma lipoprotein particle remodeling (GO:0034369) | 3.52040343 |
| 82 | reverse cholesterol transport (GO:0043691) | 3.50664627 |
| 83 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.50157558 |
| 84 | regulation of cholesterol metabolic process (GO:0090181) | 3.49442336 |
| 85 | response to mercury ion (GO:0046689) | 3.48955284 |
| 86 | ribosomal small subunit assembly (GO:0000028) | 3.45225268 |
| 87 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.43742922 |
| 88 | thioester biosynthetic process (GO:0035384) | 3.43121118 |
| 89 | acyl-CoA biosynthetic process (GO:0071616) | 3.43121118 |
| 90 | intra-S DNA damage checkpoint (GO:0031573) | 3.42857158 |
| 91 | response to nitrosative stress (GO:0051409) | 3.41307319 |
| 92 | ketone body metabolic process (GO:1902224) | 3.40294194 |
| 93 | acyl-CoA metabolic process (GO:0006637) | 3.40064465 |
| 94 | thioester metabolic process (GO:0035383) | 3.40064465 |
| 95 | aldehyde catabolic process (GO:0046185) | 3.38835351 |
| 96 | regulation of cholesterol esterification (GO:0010872) | 3.38357642 |
| 97 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.38199126 |
| 98 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.35251274 |
| 99 | nitrogen cycle metabolic process (GO:0071941) | 3.34962564 |
| 100 | plasma lipoprotein particle clearance (GO:0034381) | 3.33996997 |
| 101 | NADPH regeneration (GO:0006740) | 3.33841786 |
| 102 | drug metabolic process (GO:0017144) | 3.31989090 |
| 103 | cofactor catabolic process (GO:0051187) | 3.31262465 |
| 104 | DNA integration (GO:0015074) | 3.30532949 |
| 105 | regulation of triglyceride catabolic process (GO:0010896) | 3.30465616 |
| 106 | cellular glucuronidation (GO:0052695) | 3.30244796 |
| 107 | carboxylic acid catabolic process (GO:0046395) | 3.29873024 |
| 108 | organic acid catabolic process (GO:0016054) | 3.29873024 |
| 109 | fatty acid beta-oxidation (GO:0006635) | 3.29156452 |
| 110 | sterol biosynthetic process (GO:0016126) | 3.28634912 |
| 111 | opsonization (GO:0008228) | 3.28256870 |
| 112 | low-density lipoprotein particle remodeling (GO:0034374) | 3.28244907 |
| 113 | fatty acid oxidation (GO:0019395) | 3.26907196 |
| 114 | negative regulation of sterol transport (GO:0032372) | 3.26479236 |
| 115 | negative regulation of cholesterol transport (GO:0032375) | 3.26479236 |
| 116 | viral transcription (GO:0019083) | 3.25151097 |
| 117 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.24531233 |
| 118 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.23542960 |
| 119 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.23542960 |
| 120 | myelin maintenance (GO:0043217) | 3.22616562 |
| 121 | lipid oxidation (GO:0034440) | 3.19879548 |
| 122 | blood coagulation, intrinsic pathway (GO:0007597) | 3.19721262 |
| 123 | cholesterol efflux (GO:0033344) | 3.18630344 |
| 124 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 3.17196713 |
| 125 | translational termination (GO:0006415) | 3.15089614 |
| 126 | protein retention in ER lumen (GO:0006621) | 3.15072285 |
| 127 | hormone catabolic process (GO:0042447) | 3.09440653 |
| 128 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.06539229 |
| 129 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.06048678 |
| 130 | response to folic acid (GO:0051593) | 3.01683576 |
| 131 | toxin transport (GO:1901998) | 3.01660770 |
| 132 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.01462351 |
| 133 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.98710341 |
| 134 | translational elongation (GO:0006414) | 2.98553495 |
| 135 | DNA-dependent DNA replication (GO:0006261) | 2.96798663 |
| 136 | auditory receptor cell differentiation (GO:0042491) | 2.95609051 |
| 137 | cotranslational protein targeting to membrane (GO:0006613) | 2.92062101 |
| 138 | heart trabecula morphogenesis (GO:0061384) | 2.91989118 |
| 139 | positive regulation of response to tumor cell (GO:0002836) | 2.91091943 |
| 140 | positive regulation of immune response to tumor cell (GO:0002839) | 2.91091943 |
| 141 | regulation of immune response to tumor cell (GO:0002837) | 2.91091943 |
| 142 | regulation of response to tumor cell (GO:0002834) | 2.91091943 |
| 143 | skeletal muscle tissue regeneration (GO:0043403) | 2.90131837 |
| 144 | receptor recycling (GO:0001881) | 2.89961103 |
| 145 | desmosome organization (GO:0002934) | 2.88301577 |
| 146 | protein targeting to ER (GO:0045047) | 2.87489672 |
| 147 | protein localization to endoplasmic reticulum (GO:0070972) | 2.82659314 |
| 148 | exogenous drug catabolic process (GO:0042738) | 2.80371735 |
| 149 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.77214280 |
| 150 | regulation of early endosome to late endosome transport (GO:2000641) | 2.77125149 |
| 151 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.75271522 |
| 152 | positive regulation of icosanoid secretion (GO:0032305) | 2.71681821 |
| 153 | zinc ion transmembrane transport (GO:0071577) | 2.66198401 |
| 154 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.64148011 |
| 155 | ribosomal small subunit biogenesis (GO:0042274) | 2.63995304 |
| 156 | drug catabolic process (GO:0042737) | 2.62777762 |
| 157 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.60825454 |
| 158 | uronic acid metabolic process (GO:0006063) | 2.60038109 |
| 159 | glucuronate metabolic process (GO:0019585) | 2.60038109 |
| 160 | hepatocyte differentiation (GO:0070365) | 2.57595939 |
| 161 | fibrinolysis (GO:0042730) | 2.54746124 |
| 162 | gap junction assembly (GO:0016264) | 2.51850125 |
| 163 | ER overload response (GO:0006983) | 2.50152493 |
| 164 | proline biosynthetic process (GO:0006561) | 2.48909510 |
| 165 | blood vessel maturation (GO:0001955) | 2.48742036 |
| 166 | viral life cycle (GO:0019058) | 2.47307002 |
| 167 | hyaluronan catabolic process (GO:0030214) | 2.46299267 |
| 168 | trabecula morphogenesis (GO:0061383) | 2.45144721 |
| 169 | purine ribonucleotide transport (GO:0015868) | 2.44397108 |
| 170 | regulation of icosanoid secretion (GO:0032303) | 2.40122639 |
| 171 | monoamine transport (GO:0015844) | 2.38990625 |
| 172 | heme biosynthetic process (GO:0006783) | 2.36103953 |
| 173 | definitive hemopoiesis (GO:0060216) | 2.34902268 |
| 174 | cell adhesion mediated by integrin (GO:0033627) | 2.33387851 |
| 175 | deoxyribose phosphate catabolic process (GO:0046386) | 2.32972332 |
| 176 | peptidyl-asparagine modification (GO:0018196) | 2.30387252 |
| 177 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.30308375 |
| 178 | intestinal cholesterol absorption (GO:0030299) | 2.29684612 |
| 179 | drug transport (GO:0015893) | 2.29380907 |
| 180 | cellular protein complex disassembly (GO:0043624) | 2.27679065 |
| 181 | tight junction assembly (GO:0070830) | 2.27613239 |
| 182 | protein N-linked glycosylation (GO:0006487) | 2.27438844 |
| 183 | regulation of translational fidelity (GO:0006450) | 2.25031216 |
| 184 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 10.0724413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.82425073 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.54629839 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.52537624 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.50826965 |
| 5 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.11577716 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.05726594 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.93294141 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.84604321 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.47405798 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.35350451 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.28182137 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.74356288 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.70260474 |
| 14 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.65680056 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.64039685 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.20579826 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.17057772 |
| 18 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.00281550 |
| 19 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.99651325 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.99585625 |
| 21 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.94613752 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93068104 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.91286144 |
| 24 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.87679265 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86553226 |
| 26 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.82774691 |
| 27 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.75481350 |
| 28 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.73921205 |
| 29 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70450558 |
| 30 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.68081464 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67104450 |
| 32 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.65814714 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.64828265 |
| 34 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.56229033 |
| 35 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.56229033 |
| 36 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.56229033 |
| 37 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.55461598 |
| 38 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.55262630 |
| 39 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.54395247 |
| 40 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.51105203 |
| 41 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.50487390 |
| 42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.49274511 |
| 43 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.48858120 |
| 44 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.43636066 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.43306236 |
| 46 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40752576 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.39860848 |
| 48 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.36499582 |
| 49 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.35592395 |
| 50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35230253 |
| 51 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.35217683 |
| 52 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.34486343 |
| 53 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.32131711 |
| 54 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.32025485 |
| 55 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.25776086 |
| 56 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25441352 |
| 57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24911221 |
| 58 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.24846919 |
| 59 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.24798772 |
| 60 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.24798772 |
| 61 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.24173085 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.23505405 |
| 63 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.21481517 |
| 64 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.21050847 |
| 65 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.20947781 |
| 66 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.18364431 |
| 67 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.17548026 |
| 68 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.17457070 |
| 69 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.17158229 |
| 70 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.16425440 |
| 71 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.16119296 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16048460 |
| 73 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.15171946 |
| 74 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.13432753 |
| 75 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12745624 |
| 76 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.12612423 |
| 77 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.12554861 |
| 78 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12210138 |
| 79 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.11980049 |
| 80 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.11935613 |
| 81 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11133898 |
| 82 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10754930 |
| 83 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.10225057 |
| 84 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.09899891 |
| 85 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.09235009 |
| 86 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08699038 |
| 87 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.07467835 |
| 88 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.07285947 |
| 89 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.07156924 |
| 90 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.06916979 |
| 91 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.06629069 |
| 92 | MYC_22102868_ChIP-Seq_BL_Human | 1.06287623 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.06030640 |
| 94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05950262 |
| 95 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.05586681 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05160466 |
| 97 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.04792751 |
| 98 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04311189 |
| 99 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.02336070 |
| 100 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02033929 |
| 101 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.01746328 |
| 102 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01352175 |
| 103 | ATF3_27146783_Chip-Seq_COLON_Human | 1.00338874 |
| 104 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.00222966 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00192424 |
| 106 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99395173 |
| 107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98372624 |
| 108 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97710661 |
| 109 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92715102 |
| 110 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.91382933 |
| 111 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91127305 |
| 112 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.90881414 |
| 113 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.90291957 |
| 114 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.90048976 |
| 115 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89595674 |
| 116 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.89251899 |
| 117 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88953742 |
| 118 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.88501797 |
| 119 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.88198953 |
| 120 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.88169002 |
| 121 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87131366 |
| 122 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87029249 |
| 123 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.85957617 |
| 124 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.85754514 |
| 125 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85473403 |
| 126 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85330780 |
| 127 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.85160494 |
| 128 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.84587574 |
| 129 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.83949526 |
| 130 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.83450096 |
| 131 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.83309403 |
| 132 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82375135 |
| 133 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81509936 |
| 134 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80660397 |
| 135 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80559859 |
| 136 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.78619625 |
| 137 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.77893629 |
| 138 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.76685777 |
| 139 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.76079628 |
| 140 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.75426514 |
| 141 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.74409542 |
| 142 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.73335117 |
| 143 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.72678104 |
| 144 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.71113019 |
| 145 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.70545975 |
| 146 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.70098356 |
| 147 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69258402 |
| 148 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.67596926 |
| 149 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.66260741 |
| 150 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.65859801 |
| 151 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.65242837 |
| 152 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.64615557 |
| 153 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64030918 |
| 154 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64030918 |
| 155 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.63635456 |
| 156 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.62587012 |
| 157 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.62095597 |
| 158 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.61210747 |
| 159 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.60475766 |
| 160 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.59922104 |
| 161 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.59494204 |
| 162 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.58951733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.51689335 |
| 2 | MP0005360_urolithiasis | 6.21076130 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 5.85496048 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.99183770 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 4.62389457 |
| 6 | MP0005365_abnormal_bile_salt | 4.55553681 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 4.19031011 |
| 8 | MP0009840_abnormal_foam_cell | 3.71670835 |
| 9 | MP0003252_abnormal_bile_duct | 3.11731807 |
| 10 | MP0001835_abnormal_antigen_presentation | 3.05371001 |
| 11 | MP0003195_calcinosis | 2.90259102 |
| 12 | MP0005332_abnormal_amino_acid | 2.77126206 |
| 13 | MP0000920_abnormal_myelination | 2.75293379 |
| 14 | MP0010094_abnormal_chromosome_stability | 2.62171891 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.52441674 |
| 16 | MP0003690_abnormal_glial_cell | 2.30610560 |
| 17 | MP0002396_abnormal_hematopoietic_system | 2.29615851 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.02415287 |
| 19 | MP0003186_abnormal_redox_activity | 1.97505619 |
| 20 | MP0003329_amyloid_beta_deposits | 1.95242432 |
| 21 | MP0003656_abnormal_erythrocyte_physiolo | 1.93072476 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 1.90070925 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.89317544 |
| 24 | MP0005408_hypopigmentation | 1.89041962 |
| 25 | MP0005083_abnormal_biliary_tract | 1.86801071 |
| 26 | MP0000858_altered_metastatic_potential | 1.85773111 |
| 27 | MP0001666_abnormal_nutrient_absorption | 1.82865874 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.73484476 |
| 29 | MP0004043_abnormal_pH_regulation | 1.68643292 |
| 30 | MP0005501_abnormal_skin_physiology | 1.68524621 |
| 31 | MP0000627_abnormal_mammary_gland | 1.68292425 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.67204319 |
| 33 | MP0000609_abnormal_liver_physiology | 1.62980434 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.62591979 |
| 35 | MP0002796_impaired_skin_barrier | 1.62269176 |
| 36 | MP0004885_abnormal_endolymph | 1.61250936 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59724211 |
| 38 | MP0005171_absent_coat_pigmentation | 1.58266242 |
| 39 | MP0009379_abnormal_foot_pigmentation | 1.57238600 |
| 40 | MP0000566_synostosis | 1.52413503 |
| 41 | MP0003011_delayed_dark_adaptation | 1.49842384 |
| 42 | MP0000762_abnormal_tongue_morphology | 1.47256792 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.44919409 |
| 44 | MP0001661_extended_life_span | 1.43739824 |
| 45 | MP0004147_increased_porphyrin_level | 1.43002295 |
| 46 | MP0005058_abnormal_lysosome_morphology | 1.41569519 |
| 47 | MP0000604_amyloidosis | 1.41381383 |
| 48 | MP0003136_yellow_coat_color | 1.41155699 |
| 49 | MP0005319_abnormal_enzyme/_coenzyme | 1.39210691 |
| 50 | MP0003566_abnormal_cell_adhesion | 1.38674553 |
| 51 | MP0002060_abnormal_skin_morphology | 1.38322359 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.36032289 |
| 53 | MP0003941_abnormal_skin_development | 1.34204955 |
| 54 | MP0001764_abnormal_homeostasis | 1.30253048 |
| 55 | MP0003868_abnormal_feces_composition | 1.27597638 |
| 56 | MP0002098_abnormal_vibrissa_morphology | 1.27422269 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.21771755 |
| 58 | MP0002234_abnormal_pharynx_morphology | 1.21085721 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.16384418 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.16384418 |
| 61 | MP0003632_abnormal_nervous_system | 1.15884805 |
| 62 | MP0000490_abnormal_crypts_of | 1.14818235 |
| 63 | MP0002160_abnormal_reproductive_system | 1.10937515 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 1.10720769 |
| 65 | MP0000383_abnormal_hair_follicle | 1.08642657 |
| 66 | MP0000013_abnormal_adipose_tissue | 1.04417866 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.03604104 |
| 68 | MP0009384_cardiac_valve_regurgitation | 1.03314773 |
| 69 | MP0000462_abnormal_digestive_system | 1.03186398 |
| 70 | MP0003634_abnormal_glial_cell | 1.01355958 |
| 71 | MP0006036_abnormal_mitochondrial_physio | 1.00514471 |
| 72 | MP0000598_abnormal_liver_morphology | 1.00282030 |
| 73 | MP0010771_integument_phenotype | 0.99433766 |
| 74 | MP0009931_abnormal_skin_appearance | 0.98427253 |
| 75 | MP0005451_abnormal_body_composition | 0.98120683 |
| 76 | MP0004264_abnormal_extraembryonic_tissu | 0.97203433 |
| 77 | MP0001216_abnormal_epidermal_layer | 0.97019954 |
| 78 | MP0003111_abnormal_nucleus_morphology | 0.93504547 |
| 79 | MP0001881_abnormal_mammary_gland | 0.91721452 |
| 80 | MP0004808_abnormal_hematopoietic_stem | 0.90936180 |
| 81 | MP0005636_abnormal_mineral_homeostasis | 0.89908112 |
| 82 | MP0005174_abnormal_tail_pigmentation | 0.89251710 |
| 83 | MP0003183_abnormal_peptide_metabolism | 0.87536075 |
| 84 | MP0003315_abnormal_perineum_morphology | 0.87475466 |
| 85 | MP0001849_ear_inflammation | 0.86482076 |
| 86 | MP0003300_gastrointestinal_ulcer | 0.85999882 |
| 87 | MP0010307_abnormal_tumor_latency | 0.85071053 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.84884952 |
| 89 | MP0004381_abnormal_hair_follicle | 0.84503767 |
| 90 | MP0009053_abnormal_anal_canal | 0.84027966 |
| 91 | MP0006054_spinal_hemorrhage | 0.83654276 |
| 92 | MP0002138_abnormal_hepatobiliary_system | 0.82845640 |
| 93 | MP0005410_abnormal_fertilization | 0.82385986 |
| 94 | MP0000639_abnormal_adrenal_gland | 0.81903453 |
| 95 | MP0009763_increased_sensitivity_to | 0.81764265 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.81642126 |
| 97 | MP0000613_abnormal_salivary_gland | 0.81357904 |
| 98 | MP0003075_altered_response_to | 0.77296244 |
| 99 | MP0005266_abnormal_metabolism | 0.77232162 |
| 100 | MP0004142_abnormal_muscle_tone | 0.75256588 |
| 101 | MP0004272_abnormal_basement_membrane | 0.74617107 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.74312331 |
| 103 | MP0000358_abnormal_cell_content/ | 0.73473179 |
| 104 | MP0003943_abnormal_hepatobiliary_system | 0.72746084 |
| 105 | MP0001485_abnormal_pinna_reflex | 0.71901355 |
| 106 | MP0003631_nervous_system_phenotype | 0.70980774 |
| 107 | MP0005389_reproductive_system_phenotype | 0.70890077 |
| 108 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70708506 |
| 109 | MP0002229_neurodegeneration | 0.69797076 |
| 110 | MP0002295_abnormal_pulmonary_circulatio | 0.69700237 |
| 111 | MP0000678_abnormal_parathyroid_gland | 0.68776896 |
| 112 | MP0000350_abnormal_cell_proliferation | 0.68564929 |
| 113 | MP0005647_abnormal_sex_gland | 0.67293237 |
| 114 | MP0001348_abnormal_lacrimal_gland | 0.66945614 |
| 115 | MP0002089_abnormal_postnatal_growth/wei | 0.66506109 |
| 116 | MP0002095_abnormal_skin_pigmentation | 0.65298776 |
| 117 | MP0002090_abnormal_vision | 0.65297989 |
| 118 | MP0008932_abnormal_embryonic_tissue | 0.63935656 |
| 119 | MP0000747_muscle_weakness | 0.63594793 |
| 120 | MP0003633_abnormal_nervous_system | 0.61778507 |
| 121 | MP0001915_intracranial_hemorrhage | 0.59332538 |
| 122 | MP0003718_maternal_effect | 0.58643308 |
| 123 | MP0005220_abnormal_exocrine_pancreas | 0.56523528 |
| 124 | MP0009642_abnormal_blood_homeostasis | 0.53934915 |
| 125 | MP0001529_abnormal_vocalization | 0.53514445 |
| 126 | MP0008873_increased_physiological_sensi | 0.52612806 |
| 127 | MP0005395_other_phenotype | 0.52473703 |
| 128 | MP0004133_heterotaxia | 0.51798177 |
| 129 | MP0001756_abnormal_urination | 0.49058354 |
| 130 | MP0005023_abnormal_wound_healing | 0.47329629 |
| 131 | MP0000579_abnormal_nail_morphology | 0.46119300 |
| 132 | MP0010678_abnormal_skin_adnexa | 0.46081164 |
| 133 | MP0006035_abnormal_mitochondrial_morpho | 0.45914252 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.45599842 |
| 135 | MP0000467_abnormal_esophagus_morphology | 0.45293482 |
| 136 | MP0003283_abnormal_digestive_organ | 0.44645647 |
| 137 | MP0002092_abnormal_eye_morphology | 0.44380158 |
| 138 | MP0001958_emphysema | 0.43552690 |
| 139 | MP0000465_gastrointestinal_hemorrhage | 0.42582692 |
| 140 | MP0001324_abnormal_eye_pigmentation | 0.41936197 |
| 141 | MP0008057_abnormal_DNA_replication | 0.41349802 |
| 142 | MP0008469_abnormal_protein_level | 0.40653116 |
| 143 | MP0000372_irregular_coat_pigmentation | 0.39024091 |
| 144 | MP0002078_abnormal_glucose_homeostasis | 0.38862513 |
| 145 | MP0009697_abnormal_copulation | 0.38861022 |
| 146 | MP0001293_anophthalmia | 0.38465826 |
| 147 | MP0002877_abnormal_melanocyte_morpholog | 0.37393150 |
| 148 | MP0001243_abnormal_dermal_layer | 0.37376861 |
| 149 | MP0009764_decreased_sensitivity_to | 0.36167368 |
| 150 | MP0005167_abnormal_blood-brain_barrier | 0.35969789 |
| 151 | MP0005164_abnormal_response_to | 0.35606242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nasal polyposis (HP:0100582) | 7.54119960 |
| 2 | Chronic sinusitis (HP:0011109) | 6.40392117 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.24515421 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.23106134 |
| 5 | Abnormality of the nasal mucosa (HP:0000433) | 6.19850597 |
| 6 | Deep venous thrombosis (HP:0002625) | 5.33390105 |
| 7 | Recurrent bronchitis (HP:0002837) | 5.07113691 |
| 8 | Xanthomatosis (HP:0000991) | 5.05381582 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.97148644 |
| 10 | Hypothermia (HP:0002045) | 4.78699973 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.50132232 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 4.49963364 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 4.47251924 |
| 14 | Thick nail (HP:0001805) | 4.35946044 |
| 15 | Onycholysis (HP:0001806) | 4.12066467 |
| 16 | Plantar hyperkeratosis (HP:0007556) | 4.05566276 |
| 17 | Hyperammonemia (HP:0001987) | 3.89869590 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.87994771 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 3.87994771 |
| 20 | Ketosis (HP:0001946) | 3.85589633 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 3.83372562 |
| 22 | Hypoglycemic coma (HP:0001325) | 3.77981905 |
| 23 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.77897236 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.75382697 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.68416428 |
| 26 | Neurofibrillary tangles (HP:0002185) | 3.68380642 |
| 27 | Delayed CNS myelination (HP:0002188) | 3.47564226 |
| 28 | Hyperglycinemia (HP:0002154) | 3.38003938 |
| 29 | Complement deficiency (HP:0004431) | 3.33950887 |
| 30 | Hyperglycinuria (HP:0003108) | 3.32291307 |
| 31 | Milia (HP:0001056) | 3.32116020 |
| 32 | Fragile nails (HP:0001808) | 3.31540361 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.29047049 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.28479743 |
| 35 | Palmoplantar hyperkeratosis (HP:0000972) | 3.28038563 |
| 36 | Abnormality of the common coagulation pathway (HP:0010990) | 3.26394924 |
| 37 | Hypolipoproteinemia (HP:0010981) | 3.24818919 |
| 38 | Fat malabsorption (HP:0002630) | 3.23894214 |
| 39 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.18901934 |
| 40 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.18901934 |
| 41 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.18694524 |
| 42 | Acute lymphatic leukemia (HP:0006721) | 3.17752027 |
| 43 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.17274044 |
| 44 | Periodontitis (HP:0000704) | 3.10688963 |
| 45 | Palmar hyperkeratosis (HP:0010765) | 3.07325360 |
| 46 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.05935349 |
| 47 | Epidermoid cyst (HP:0200040) | 3.05807125 |
| 48 | Joint hemorrhage (HP:0005261) | 3.03847398 |
| 49 | Abnormality of glycolipid metabolism (HP:0010969) | 2.99195500 |
| 50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.99195500 |
| 51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.99195500 |
| 52 | Pustule (HP:0200039) | 2.93779642 |
| 53 | Amyloidosis (HP:0011034) | 2.92178257 |
| 54 | Abnormality of the intrinsic pathway (HP:0010989) | 2.88995653 |
| 55 | Flattened epiphyses (HP:0003071) | 2.86828330 |
| 56 | Thoracic kyphosis (HP:0002942) | 2.84877852 |
| 57 | Abnormality of nail color (HP:0100643) | 2.82881142 |
| 58 | Ketoacidosis (HP:0001993) | 2.81898329 |
| 59 | Cerebral inclusion bodies (HP:0100314) | 2.81856948 |
| 60 | Hyperbilirubinemia (HP:0002904) | 2.81059888 |
| 61 | Spastic diplegia (HP:0001264) | 2.80278568 |
| 62 | Agammaglobulinemia (HP:0004432) | 2.79121901 |
| 63 | Bronchitis (HP:0012387) | 2.77230040 |
| 64 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.70094621 |
| 65 | Dicarboxylic aciduria (HP:0003215) | 2.70094621 |
| 66 | Steatorrhea (HP:0002570) | 2.68285883 |
| 67 | Hypoalphalipoproteinemia (HP:0003233) | 2.67553904 |
| 68 | Pili torti (HP:0003777) | 2.67330921 |
| 69 | Spastic paraparesis (HP:0002313) | 2.66298371 |
| 70 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.64260049 |
| 71 | Global brain atrophy (HP:0002283) | 2.59520743 |
| 72 | Abnormality of serum amino acid levels (HP:0003112) | 2.55440840 |
| 73 | Mitral stenosis (HP:0001718) | 2.54847760 |
| 74 | 11 pairs of ribs (HP:0000878) | 2.52838412 |
| 75 | Thrombocytosis (HP:0001894) | 2.51374260 |
| 76 | Increased cerebral lipofuscin (HP:0011813) | 2.48311399 |
| 77 | Hepatocellular carcinoma (HP:0001402) | 2.48263420 |
| 78 | Axonal loss (HP:0003447) | 2.47224850 |
| 79 | Abnormality of the corticospinal tract (HP:0002492) | 2.44762656 |
| 80 | Abnormality of nucleobase metabolism (HP:0010932) | 2.42391714 |
| 81 | Hypercholesterolemia (HP:0003124) | 2.40663028 |
| 82 | Ectopia lentis (HP:0001083) | 2.40520752 |
| 83 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.39651180 |
| 84 | Atrophic scars (HP:0001075) | 2.39137813 |
| 85 | Emphysema (HP:0002097) | 2.37141007 |
| 86 | Abnormality of the thoracic spine (HP:0100711) | 2.36795578 |
| 87 | Albinism (HP:0001022) | 2.36570844 |
| 88 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.33035169 |
| 89 | Abnormality of complement system (HP:0005339) | 2.32618161 |
| 90 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.31845853 |
| 91 | Termporal pattern (HP:0011008) | 2.28405536 |
| 92 | Insidious onset (HP:0003587) | 2.28405536 |
| 93 | Dysostosis multiplex (HP:0000943) | 2.26977562 |
| 94 | Vacuolated lymphocytes (HP:0001922) | 2.26872537 |
| 95 | Cerebral hypomyelination (HP:0006808) | 2.26454220 |
| 96 | Cholecystitis (HP:0001082) | 2.26296348 |
| 97 | Abnormal gallbladder physiology (HP:0012438) | 2.26296348 |
| 98 | Amelogenesis imperfecta (HP:0000705) | 2.25772166 |
| 99 | Hypochromic microcytic anemia (HP:0004840) | 2.25084464 |
| 100 | Hypoglycemic seizures (HP:0002173) | 2.24974810 |
| 101 | Irritability (HP:0000737) | 2.23327781 |
| 102 | Lethargy (HP:0001254) | 2.23206208 |
| 103 | Vascular calcification (HP:0004934) | 2.21977779 |
| 104 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.18400915 |
| 105 | Osteolytic defects of the hand bones (HP:0009699) | 2.18400915 |
| 106 | Generalized aminoaciduria (HP:0002909) | 2.18001068 |
| 107 | Abnormal hair laboratory examination (HP:0003328) | 2.16713676 |
| 108 | Brushfield spots (HP:0001088) | 2.16472581 |
| 109 | Enlarged epiphyses (HP:0010580) | 2.14572013 |
| 110 | Metabolic acidosis (HP:0001942) | 2.13343032 |
| 111 | Increased serum pyruvate (HP:0003542) | 2.12638392 |
| 112 | Abnormality of glycolysis (HP:0004366) | 2.12638392 |
| 113 | Abnormal auditory evoked potentials (HP:0006958) | 2.12090639 |
| 114 | Abnormal gallbladder morphology (HP:0012437) | 2.09659350 |
| 115 | Hypophosphatemic rickets (HP:0004912) | 2.08272966 |
| 116 | Cardiovascular calcification (HP:0011915) | 2.07404321 |
| 117 | Conjugated hyperbilirubinemia (HP:0002908) | 2.05581156 |
| 118 | Abnormality of purine metabolism (HP:0004352) | 2.04240308 |
| 119 | Peripheral demyelination (HP:0011096) | 2.03347031 |
| 120 | Alkalosis (HP:0001948) | 2.03256013 |
| 121 | Nail dystrophy (HP:0008404) | 2.02380533 |
| 122 | Epiphyseal stippling (HP:0010655) | 2.02321957 |
| 123 | Skin nodule (HP:0200036) | 2.00840022 |
| 124 | Gout (HP:0001997) | 2.00231110 |
| 125 | Chronic otitis media (HP:0000389) | 11.0872924 |
| 126 | Generalized amyotrophy (HP:0003700) | 1.99929412 |
| 127 | Hypoplasia of the fovea (HP:0007750) | 1.99648879 |
| 128 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.99648879 |
| 129 | Confusion (HP:0001289) | 1.98953430 |
| 130 | Ankyloglossia (HP:0010296) | 1.98784126 |
| 131 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98593672 |
| 132 | Cerebral edema (HP:0002181) | 1.97886827 |
| 133 | Abnormal cartilage morphology (HP:0002763) | 1.97096854 |
| 134 | Intention tremor (HP:0002080) | 1.96680963 |
| 135 | Flat acetabular roof (HP:0003180) | 1.96579413 |
| 136 | Acanthocytosis (HP:0001927) | 1.95574003 |
| 137 | Congenital stationary night blindness (HP:0007642) | 1.95017410 |
| 138 | Abnormality of vitamin metabolism (HP:0100508) | 1.92468942 |
| 139 | Abnormal blistering of the skin (HP:0008066) | 1.91731307 |
| 140 | Paraparesis (HP:0002385) | 1.91633566 |
| 141 | Peripheral hypomyelination (HP:0007182) | 1.91314298 |
| 142 | Malnutrition (HP:0004395) | 1.90941239 |
| 143 | Increased circulating renin level (HP:0000848) | 1.90826382 |
| 144 | Cholelithiasis (HP:0001081) | 1.90334833 |
| 145 | Abnormality of oral frenula (HP:0000190) | 1.88766466 |
| 146 | Hemorrhage of the eye (HP:0011885) | 1.88192477 |
| 147 | Megaloblastic anemia (HP:0001889) | 1.88085740 |
| 148 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.87751752 |
| 149 | Abnormality of the alveolar ridges (HP:0006477) | 1.87699827 |
| 150 | Opisthotonus (HP:0002179) | 1.86856688 |
| 151 | Back pain (HP:0003418) | 1.85598029 |
| 152 | Turricephaly (HP:0000262) | 1.83883888 |
| 153 | White forelock (HP:0002211) | 1.82863891 |
| 154 | Rickets (HP:0002748) | 1.80552009 |
| 155 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.80182744 |
| 156 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.80182744 |
| 157 | Vomiting (HP:0002013) | 1.79758675 |
| 158 | Skin ulcer (HP:0200042) | 1.79724274 |
| 159 | Glycosuria (HP:0003076) | 1.79523209 |
| 160 | Ridged nail (HP:0001807) | 1.78579962 |
| 161 | Missing ribs (HP:0000921) | 1.78491717 |
| 162 | Impulsivity (HP:0100710) | 1.78139287 |
| 163 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.77387554 |
| 164 | Central scotoma (HP:0000603) | 1.77170858 |
| 165 | Constricted visual fields (HP:0001133) | 1.77156659 |
| 166 | Pseudobulbar signs (HP:0002200) | 1.75472188 |
| 167 | Glomerulosclerosis (HP:0000096) | 1.74921110 |
| 168 | Focal segmental glomerulosclerosis (HP:0000097) | 1.74569096 |
| 169 | Mucopolysacchariduria (HP:0008155) | 1.74192421 |
| 170 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.74192421 |
| 171 | Alopecia of scalp (HP:0002293) | 1.72813479 |
| 172 | Patchy hypopigmentation of hair (HP:0011365) | 1.72669537 |
| 173 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.72202207 |
| 174 | Premature loss of primary teeth (HP:0006323) | 1.70426863 |
| 175 | Abnormal number of erythroid precursors (HP:0012131) | 1.70236054 |
| 176 | Severe visual impairment (HP:0001141) | 1.68858660 |
| 177 | B lymphocytopenia (HP:0010976) | 1.67588995 |
| 178 | Increased serum ferritin (HP:0003281) | 1.67378757 |
| 179 | Personality changes (HP:0000751) | 1.66164897 |
| 180 | Reduced antithrombin III activity (HP:0001976) | 1.63423202 |
| 181 | Abnormality of macular pigmentation (HP:0008002) | 1.63275150 |
| 182 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.63172035 |
| 183 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.63172035 |
| 184 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.63172035 |
| 185 | Natal tooth (HP:0000695) | 1.62658357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.26358844 |
| 2 | ARAF | 4.56461113 |
| 3 | EPHB1 | 4.40370657 |
| 4 | STK39 | 4.25514869 |
| 5 | TLK1 | 3.43502746 |
| 6 | MAP3K9 | 3.39787523 |
| 7 | OXSR1 | 3.35813575 |
| 8 | MET | 3.16382559 |
| 9 | TESK2 | 2.71705878 |
| 10 | MAP3K14 | 2.48145246 |
| 11 | WNK4 | 2.27373848 |
| 12 | BRAF | 2.21416561 |
| 13 | SIK1 | 2.19875482 |
| 14 | BMPR2 | 2.17186487 |
| 15 | MAPKAPK5 | 2.10345543 |
| 16 | PIM2 | 1.94976874 |
| 17 | NME2 | 1.89872116 |
| 18 | PKN2 | 1.79090083 |
| 19 | WEE1 | 1.63283733 |
| 20 | FGFR2 | 1.61706938 |
| 21 | PBK | 1.56421304 |
| 22 | ERBB4 | 1.55284132 |
| 23 | CSNK1G3 | 1.52279863 |
| 24 | MAP3K12 | 1.48748084 |
| 25 | NTRK1 | 1.47120751 |
| 26 | STK16 | 1.46614658 |
| 27 | MST1R | 1.46382257 |
| 28 | INSRR | 1.42132090 |
| 29 | PKN1 | 1.41007979 |
| 30 | SCYL2 | 1.38709501 |
| 31 | ILK | 1.37915465 |
| 32 | CSNK1A1L | 1.36931958 |
| 33 | RAF1 | 1.32892047 |
| 34 | LRRK2 | 1.32228824 |
| 35 | CSNK1G1 | 1.31359263 |
| 36 | TAOK3 | 1.22594991 |
| 37 | ERN1 | 1.22491435 |
| 38 | TYRO3 | 1.18646088 |
| 39 | CDK12 | 1.18532085 |
| 40 | GSK3A | 1.18210981 |
| 41 | TTK | 1.16766781 |
| 42 | KSR2 | 1.12843055 |
| 43 | ABL2 | 1.12153706 |
| 44 | MAPK15 | 1.11111754 |
| 45 | PTK6 | 1.08454657 |
| 46 | MAP3K8 | 1.06916508 |
| 47 | STK38L | 1.06743330 |
| 48 | CLK1 | 1.04696957 |
| 49 | LIMK1 | 1.03766090 |
| 50 | FLT3 | 1.03082485 |
| 51 | ICK | 0.99878359 |
| 52 | CSNK1G2 | 0.98588927 |
| 53 | LATS1 | 0.96013751 |
| 54 | SGK223 | 0.92230238 |
| 55 | SGK494 | 0.92230238 |
| 56 | DDR2 | 0.92137432 |
| 57 | IRAK3 | 0.91713612 |
| 58 | IRAK2 | 0.91149300 |
| 59 | MAP3K6 | 0.90028149 |
| 60 | LMTK2 | 0.88156080 |
| 61 | TRIB3 | 0.87241329 |
| 62 | MAPK11 | 0.87068774 |
| 63 | ROCK2 | 0.86146873 |
| 64 | UHMK1 | 0.86138514 |
| 65 | BUB1 | 0.82109672 |
| 66 | BMX | 0.81330967 |
| 67 | WNK3 | 0.81222338 |
| 68 | CSK | 0.80417843 |
| 69 | FGFR4 | 0.78988719 |
| 70 | PAK4 | 0.77381321 |
| 71 | BRD4 | 0.76055317 |
| 72 | NEK2 | 0.73940439 |
| 73 | MAP3K2 | 0.72568293 |
| 74 | WNK1 | 0.72383540 |
| 75 | RPS6KB2 | 0.69824982 |
| 76 | BTK | 0.68429522 |
| 77 | CDK7 | 0.65901850 |
| 78 | ATR | 0.65857143 |
| 79 | IKBKB | 0.64933949 |
| 80 | VRK2 | 0.64305894 |
| 81 | KIT | 0.64186295 |
| 82 | MATK | 0.64138861 |
| 83 | MAP2K2 | 0.63592957 |
| 84 | JAK2 | 0.61928374 |
| 85 | NEK1 | 0.61898570 |
| 86 | GRK6 | 0.61687163 |
| 87 | PAK2 | 0.61626138 |
| 88 | TRPM7 | 0.59496208 |
| 89 | CAMK2B | 0.58734612 |
| 90 | BRSK2 | 0.58294074 |
| 91 | STK10 | 0.57227562 |
| 92 | CDC7 | 0.56766801 |
| 93 | MAP3K7 | 0.55764867 |
| 94 | CAMK2G | 0.55500994 |
| 95 | CSNK1D | 0.55426409 |
| 96 | KDR | 0.55205659 |
| 97 | EIF2AK1 | 0.52392758 |
| 98 | DYRK2 | 0.51051538 |
| 99 | KSR1 | 0.50972432 |
| 100 | MOS | 0.50421355 |
| 101 | PTK2 | 0.49720422 |
| 102 | VRK1 | 0.49541513 |
| 103 | CDK19 | 0.48687109 |
| 104 | EEF2K | 0.47498993 |
| 105 | ZAK | 0.47074136 |
| 106 | IRAK1 | 0.45971777 |
| 107 | MAP3K1 | 0.45474731 |
| 108 | RET | 0.44679396 |
| 109 | TGFBR1 | 0.44343369 |
| 110 | CAMK2D | 0.43934963 |
| 111 | AURKB | 0.42707534 |
| 112 | CSF1R | 0.42019607 |
| 113 | FES | 0.41060620 |
| 114 | PAK3 | 0.40301826 |
| 115 | PASK | 0.39593649 |
| 116 | MAP3K11 | 0.39387106 |
| 117 | PDPK1 | 0.39233349 |
| 118 | TESK1 | 0.38066416 |
| 119 | PRKCQ | 0.37913249 |
| 120 | MAP3K13 | 0.37582293 |
| 121 | PINK1 | 0.37449881 |
| 122 | CHUK | 0.36759259 |
| 123 | MAPK4 | 0.36475222 |
| 124 | SRPK1 | 0.36474983 |
| 125 | PRKD3 | 0.36428002 |
| 126 | MAPKAPK3 | 0.36307727 |
| 127 | ERBB2 | 0.36263655 |
| 128 | DAPK1 | 0.35566213 |
| 129 | PAK1 | 0.35246640 |
| 130 | PRKD1 | 0.35048888 |
| 131 | CDK6 | 0.33840084 |
| 132 | EPHA4 | 0.33693498 |
| 133 | PRPF4B | 0.33535030 |
| 134 | STK4 | 0.33248934 |
| 135 | MTOR | 0.33181468 |
| 136 | PRKACB | 0.32963449 |
| 137 | CHEK1 | 0.32223678 |
| 138 | EPHA2 | 0.32007380 |
| 139 | CDK4 | 0.31348803 |
| 140 | NEK9 | 0.29682804 |
| 141 | STK3 | 0.29570602 |
| 142 | PLK1 | 0.29204452 |
| 143 | CHEK2 | 0.28112624 |
| 144 | SMG1 | 0.27897734 |
| 145 | AURKA | 0.26590072 |
| 146 | DAPK3 | 0.25890046 |
| 147 | MAP2K6 | 0.25497775 |
| 148 | MAP2K3 | 0.24545131 |
| 149 | CSNK2A1 | 0.24534085 |
| 150 | ZAP70 | 0.23272825 |
| 151 | MAP2K1 | 0.23130847 |
| 152 | RPS6KA4 | 0.22668768 |
| 153 | EIF2AK3 | 0.22630495 |
| 154 | IGF1R | 0.22590026 |
| 155 | MAP3K5 | 0.21797552 |
| 156 | ATM | 0.20509945 |
| 157 | TYK2 | 0.19065670 |
| 158 | AKT2 | 0.18588407 |
| 159 | CSNK2A2 | 0.18540301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.76687169 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.35652207 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.27277173 |
| 4 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.93901725 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.88520285 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.52920569 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.52613540 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.40909536 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.33006064 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.29992836 |
| 11 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.25390910 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.24517056 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24507543 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.11952379 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.10264896 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07507418 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 2.07413635 |
| 18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.06803154 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.02099315 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.00416847 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.98340105 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92601481 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.90986596 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.85162355 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.82614760 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.78589966 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75083940 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.70306114 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.65999942 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.65893596 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.64529651 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63062749 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.58738543 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.58561812 |
| 35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.54913864 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.51334186 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.50193966 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.46232808 |
| 39 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.35713172 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.35287507 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34898735 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.34204774 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.31740509 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.30933408 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.30135471 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.30106547 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.29706325 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.29270251 |
| 49 | Bladder cancer_Homo sapiens_hsa05219 | 1.27671678 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26680878 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23969357 |
| 52 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.21196374 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.18862349 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.17523039 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 1.15930833 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15668574 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.15148361 |
| 58 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.14377062 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.06796309 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 1.06248081 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06171674 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.03530692 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.02548238 |
| 64 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.01791943 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96304786 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95927447 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93265999 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91569277 |
| 69 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.91168063 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87038712 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86896967 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85515827 |
| 73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82218424 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79964924 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77680481 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.77079308 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.73068880 |
| 78 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72506083 |
| 79 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.68994062 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.68856727 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65809265 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65653755 |
| 83 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.65123005 |
| 84 | Spliceosome_Homo sapiens_hsa03040 | 0.64974946 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.62823241 |
| 86 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.60683413 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.60525625 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59806114 |
| 89 | Apoptosis_Homo sapiens_hsa04210 | 0.59461587 |
| 90 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59122886 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56267893 |
| 92 | Protein export_Homo sapiens_hsa03060 | 0.53877699 |
| 93 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50184299 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47587645 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44268496 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42590572 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41534446 |
| 98 | DNA replication_Homo sapiens_hsa03030 | 0.40904777 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36841617 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34748021 |
| 101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32862072 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | 0.27157364 |
| 103 | Lysosome_Homo sapiens_hsa04142 | 0.26817133 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.23392981 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22702118 |
| 106 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21841635 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21388223 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19802500 |
| 109 | Mismatch repair_Homo sapiens_hsa03430 | 0.19284540 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18941192 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18711489 |
| 112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.18672385 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.16557103 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16473242 |
| 115 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.07263353 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.06285632 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.03268413 |
| 118 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.02641120 |
| 119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.02132148 |
| 120 | Nucleotide excision repair_Homo sapiens_hsa03420 | -0.0575384 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.0572573 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | -0.0529942 |
| 123 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0450772 |
| 124 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0438046 |
| 125 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0401043 |
| 126 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0182865 |

